Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 20, 2021
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of September 12, 2021
Breast cancer researchers from Hutch / UW Cancer Consortium gain BCRF funding
New grants will support studies aimed at bettering patient outcomes through diet, exercise, vaccines and more
Breast Cancer Research Foundation funds 8 Fred Hutch/UW Cancer Consortium scientists
Nearly $2M will go toward potential therapies for metastatic disease and better risk reduction through diet and exercise
The hidden function of anti-tumoral drug Motolimod to target immunosuppressive cells
from Dr. Nora Disis, Clinical Research Division
Good News: Normal skin cells keep cancer at bay
Celebrating faculty and staff achievements
6 questions in cancer immunotherapy
From cancer vaccines to engineered T cells, experts weigh in on the big unknowns
New breast cancer vaccine ‘promising but not ready for prime time’
Vaccine potentially could be used in the majority of breast cancer patients
Cancer Immunotherapy Trials Network selects member sites
Center-based initiative announces 27 institutional partners in national research effort to accelerate clinical trials of promising cancer immunotherapies
Fred Hutchinson Cancer Research Center to lead immunotherapy clinical trials network
More than two dozen research institutes in the U.S. and Canada to participate
$17 million award launches Cancer Immunotherapy Trials Network
Center to lead national, multi-institutional clinical trials effort
Removing roadblocks to tumor treatment
Nora Disis and colleagues find promise in expanded T-cell therapy for vaccinated cancer patients with advanced stage tumors
Harnessing cancer's inner enemy
UW, Center collaborative study on innate immunity to ovarian-cancer protein paves way for new immune-based therapies for the disease